These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15129244)

  • 1. AIDS drug price hike prompts calls for intervention.
    Check E
    Nature; 2004 May; 429(6987):6. PubMed ID: 15129244
    [No Abstract]   [Full Text] [Related]  

  • 2. Petition fails to reverse massive price rise for AIDS drug.
    Check E
    Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778
    [No Abstract]   [Full Text] [Related]  

  • 3. Patents. NIH declines to march in on pricing AIDS drug.
    Malakoff D
    Science; 2004 Aug; 305(5686):926. PubMed ID: 15310867
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents.
    Malakoff D
    Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775
    [No Abstract]   [Full Text] [Related]  

  • 5. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir.
    Huff B
    GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug pricing. AHF sues Abbott over drug price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethics and AIDS drugs.
    Dowell W
    Time; 1999 Jul; 154(2):49. PubMed ID: 10538646
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS activists fail to block 'reasonable pricing' reform.
    Gavaghan H
    Nature; 1995 Jan; 373(6512):272. PubMed ID: 7830751
    [No Abstract]   [Full Text] [Related]  

  • 9. 400 percent ritonavir price hike.
    Alcorn K
    IAPAC Mon; 2004 Jan; 10(1):6-7. PubMed ID: 15108670
    [No Abstract]   [Full Text] [Related]  

  • 10. Backlash over ritonavir price hike.
    Huff B
    BETA; 2004; 16(4):15-7. PubMed ID: 15386839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA issues warning letter to Abbott over Norvir pricing spin.
    GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439
    [No Abstract]   [Full Text] [Related]  

  • 12. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversy over ritonavir price increase.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032179
    [No Abstract]   [Full Text] [Related]  

  • 14. Global AIDS trial denied patients as US balks at generic drug use.
    Check E
    Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccine 'needs focused effort' as drug firms back off research.
    Butler D
    Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug pricing. AHF presses for indemnification over Norvir price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045980
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug company raises US price of AIDS drug five-fold.
    Charatan F
    BMJ; 2004 Apr; 328(7446):974. PubMed ID: 15105312
    [No Abstract]   [Full Text] [Related]  

  • 19. Abbott Laboratories increases Norvir price fivefold.
    James JS
    AIDS Treat News; 2003 Dec; (397):3-5. PubMed ID: 14989182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debate over ritonavir price increase gains momentum. Critics seek to reverse the fivefold price hike through legal action and boycott of Abbott's products.
    Nelson R
    Lancet; 2004 Apr; 363(9418):1369. PubMed ID: 15114988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.